Global edition
Region
NewsCase StudiesWebcastsInterviewsEventsPodcastsMagazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Leadership
  • AI in Pharma
  • Manufacturing
  • Marketing
  • HR in Pharma
  • Microbiology & CCS
  • Regulatory Landscape
Formats
  • News & Analysis
  • Interviews
  • Case Studies
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
  • Partner with us
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Home/Case Studies/Quality 4.0
Q&A Case studyQuality 4.0

A Quality 4.0 Analytics Layer Above Legacy LIMS and MES

Dr. Reddy's knitted six site-level LIMS instances and two MES vintages into a single quality analytics layer that surfaces process drift before it becomes a deviation.

Fewer trend-triggered investigations year on year
47%
Priya Nair
The practitioner
Priya Nair
Chief Quality Officer, Dr. Reddy's Laboratories
Interview by Mrudula Kulkarni
Managing Editor - Pharma Now
15 Jul 2026 · 8 min read
The challenge
Across six manufacturing sites, quality signals lived in siloed LIMS instances and two generations of MES.
The approach
Rather than a rip-and-replace, the team built an analytics layer that read from the source systems in near real time and normalised results…
The result
The layer went live at all six sites within nine months.
A Quality 4.0 Analytics Layer Above Legacy LIMS and MES

The challenge

Across six manufacturing sites, quality signals lived in siloed LIMS instances and two generations of MES. Trend analysis was largely manual and reactive, and the corporate quality council was consistently seeing signals in the monthly review that a shift-level operator could have caught days earlier.

The approach

Rather than a rip-and-replace, the team built an analytics layer that read from the source systems in near real time and normalised results into a common process performance model. Statistical process control charts were wired to shop-floor dashboards, and a lightweight signal-triage workflow was co-designed with QA leads at each site.

The result

The layer went live at all six sites within nine months. Deviations trending toward investigation dropped notably, average time-to-signal shortened from days to hours, and the corporate council refocused monthly reviews on systemic issues rather than site-level firefighting.

Q

Why not just consolidate the LIMS instances?

We priced that out first. Consolidating six LIMS to one would have been a three-year programme with a nine-figure budget, and would have frozen the release process during migration.

The analytics layer gave us most of the value — cross-site visibility, faster triage, systemic trending — without touching the source systems. Consolidation can still happen later; we just moved the value forward.

Q

How did you standardise data across two MES generations?

We built a canonical process performance model that lived above both MES vintages. Each source system had a thin adapter that mapped its native tags to the canonical model.

When we onboarded a new site, the adapter was the only thing we wrote — the analytics layer above stayed unchanged.

Q

How did the site QA leads react to shop-floor SPC charts?

Cautiously at first. There was a real fear that signals on a dashboard would lead to over-reaction and unnecessary investigations.

We co-designed a lightweight signal-triage workflow with the QA leads themselves — three tiers of severity, clear escalation criteria, and a "watch" state that didn't auto-generate a deviation. That got them onside.

We stopped trying to replace the source systems. We started asking better questions of them.

Priya Nair, Chief Quality Officer
Measured impact
47%
Fewer trend-triggered investigations year on year
4.2 h
Median time to signal
6
Sites live within nine months

The method, in brief

1
Inventory every quality data source across six sites — Cataloged every LIMS instance, MES vintage, and standalone quality database. Identified the ~40 signal streams that mattered for cross-site trending.
2
Build a canonical process performance model — Defined the common data model above the source systems. Every downstream chart, alert, and dashboard reads from the canonical model, not the source.
3
Write thin adapters per source system — One adapter per LIMS instance and MES vintage, mapping native tags to the canonical model. Adapters are the only per-site code — everything above is shared.
4
Co-design the signal-triage workflow with site QA — Sat with QA leads at each site to define severity tiers and escalation criteria. The "watch" state without auto-generated deviations was the unlock.
5
Roll out one site per month — Sequenced the rollout to give each site a full month of adoption before adding the next. All six sites live within nine months.
Download PDF
Share

Discussion

Loading discussion…
Case facts
SiteHyderabad, India (multi-site)
SectorAPI and finished dose
RegionAPAC / North America
ProgrammeQuality 4.0
TeamQA, IT, Data Engineering
Reviewed byDr. Meera Iyer, VP Manufacturing Operations
Pitch your own result
About the practitioner
Priya Nair
Priya Nair
Chief Quality Officer, Dr. Reddy's Laboratories

Priya architected the Quality 4.0 roadmap at Dr. Reddy's, folding analytics into every stage of the release process.

Independently reviewed

Method and data verified by a Pharma Now editor and an external subject expert before publication.

More case studies

All case studies
Closing the Annex 1 Gap on a Legacy Fill-Finish LineQ&A
Sterile Manufacturing

Closing the Annex 1 Gap on a Legacy Fill-Finish Line

58%Reduction in manual interventions per batch
9 min
From Batch to Continuous: Rewiring an OSD Product for Steady-State ManufactureQ&A
Continuous Manufacturing

From Batch to Continuous: Rewiring an OSD Product for Steady-State Manufacture

38%Reduction in end-to-end cycle time
11 min
Retiring Paper Batch Records Across a Commercial Biologics CampusQ&A
Digital Batch Records

Retiring Paper Batch Records Across a Commercial Biologics Campus

85%Reduction in batch review lead time
10 min
Have a result worth sharing?

Pitch a case study from your site.

If you have changed a method and have the data to show for it, our editors would like to hear from you — in confidence, with no obligation to publish.